Right On Brands Stock (OTC:RTON), Trade Ideas

Right On Brands Inc is a Texas based consumer goods company which provides traditional, plus natural health and wellness information services through an interactive website. The company business is conducted through wholly-owned subsidiaries, Humbly Hemp, Endo Brands, and Humble Water Company. Humbly Hemp sells and markets a line of hemp enhanced snack foods. Humble Water Company is in a partnership with Springhill Water Co. to develop a line of High Alkaline, Natural Mineral Water, and a bottling and packaging facility. The company has two operating segments: ENDO Brands and Humbly Hemp. ENDO Brands develops hemp oil-infused products which are engineered to deliver optimal bioavailability and nutrients to the body and Humbly Hemp develops a line of hemp based bars and drinks.

Cannabis dispensary roundup (Shutterstock)(16)

Cannabis

News

Entrepreneurship

Retail Sales

ACRDF

CNTMF

CSE:ACRG

CSE:PLTH

CSE:TIUM

CSE:TRUL

CSE:VEXT

PLNH

RIGHT ON BRANDS INC by Right On Brands, Inc.

RTON

TCNNF

TRUL

VEXTF

Here&#39;s Where To Buy And Consume Weed: New Cannabis Shops, Consumption Lounges And More

budding-h3PWUqxpP_0-unsplash(31)

CNPOF

CSE:RIV

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

TSX:CURA

VRNOF

The cannabis revolution continues to grow with new dispensary openings across seven states. In Texas, Right on Brands and Texas Original launched new retail locations, while New York welcomed RIV Capital and Etain&#39;s new co-located dispensary. NYC Bud in Long Island City offers a unique subway-themed shopping experience. Additionally, CODES opened a new pop-up in Missouri, Curaleaf relocated its Phoenix Airport dispensary in Arizona, Sweetspot Farms launched a new store in Connecticut, Trulieve Cannabis Corp. expanded in Florida, and Verano Holdings Corp. added Zen Leaf Norristown to its Pennsylvania locations. These latest openings underscore the increasing acceptance and accessibility of cannabis products for both medical patients and recreational consumers nationwide.

Here&#39;s Where To Buy Legal Weed: Seven States Open New Cannabis Dispensaries

Markets

Right on Brands Inc’s (OTCPK:RTON) board of directors has approved a 1-for-250 reverse stock split of its ordinary common shares. After the split the total authorized shares will be reduced to one-hundred million common shares with no par value.

Right On Brands Announces Reverse Split

Right On Brands Inc

Baird analyst David Manthey maintains Watsco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSO#NYSE">WSO</a>) with a Outperform and raises the price target from $420 to $460.

Price Target

Analyst Ratings

Baird Maintains Outperform on Watsco, Raises Price Target to $460

Guidance

NDAQ

Nasdaq Sees FY24 Non-GAAP Operating Expense $2.125B-$2.185B

Newmont (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>) reported quarterly earnings of $0.55 per share which beat the analyst consensus estimate of $0.36 by 52.78 percent. The company reported quarterly sales of $4.023 billion which beat the analyst consensus estimate of $3.670 billion by 9.62 percent. This is a 50.17 percent increase over sales of $2.679 billion the same period last year.

Earnings

Earnings Beats

Newmont Q1 2024 Adj EPS $0.55 Beats $0.36 Estimate, Sales $4.023B Beat $3.670B Estimate

Expro Gr Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPRO#NYSE">XPRO</a>) reported quarterly earnings of $0.09 per share which missed the analyst consensus estimate of $0.12 by 25 percent. This is a 800 percent increase over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $383.489 million which beat the analyst consensus estimate of $369.621 million by 3.75 percent. This is a 13.03 percent increase over sales of $339.279 million the same period last year.

Earnings Misses

XPRO

Expro Gr Hldgs Q1 2024 Adj EPS $0.09 Misses $0.12 Estimate, Sales $383.489M Beat $369.621M Estimate

Bristol-Myers Squibb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) reported quarterly losses of $(4.40) per share which beat the analyst consensus estimate of $(4.44) by 0.9 percent. This is a 314.63 percent decrease over earnings of $2.05 per share from the same period last year. The company reported quarterly sales of $11.865 billion which beat the analyst consensus estimate of $11.458 billion by 3.56 percent. This is a 4.66 percent increase over sales of $11.337 billion the same period last year.

Bristol-Myers Squibb Q1 2024 Adj EPS $(4.40) Beats $(4.44) Estimate, Sales $11.865B Beat $11.458B Estimate

Stericycle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRCL#NASDAQ">SRCL</a>) reported quarterly earnings of $0.57 per share which met the analyst consensus estimate. This is a 16.33 percent increase over earnings of $0.49 per share from the same period last year. The company reported quarterly sales of $664.900 million which missed the analyst consensus estimate of $679.277 million by 2.12 percent. This is a 2.84 percent decrease over sales of $684.300 million the same period last year.

SRCL

Stericycle Q2 2024 GAAP EPS $0.57, Inline, Sales $664.900M Miss $679.277M Estimate

HC Wainwright &amp; Co. analyst Douglas Tsao maintains Evotec (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVO#NASDAQ">EVO</a>) with a Buy and lowers the price target from $14 to $11.

HC Wainwright & Co. Maintains Buy on Evotec, Lowers Price Target to $11

Baird analyst Michael Halloran maintains Veralto (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLTO#NYSE">VLTO</a>) with a Neutral and raises the price target from $90 to $98.

VLTO

Baird Maintains Neutral on Veralto, Raises Price Target to $98

Altisource Portfolio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASPS#NASDAQ">ASPS</a>) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.39) by 48.72 percent. The company reported quarterly sales of $36.891 million which beat the analyst consensus estimate of $34.977 million by 5.47 percent. This is a 0.49 percent decrease over sales of $37.071 million the same period last year.

ASPS

Altisource Portfolio Q1 2024 Adj EPS $(0.20) Beats $(0.39) Estimate, Sales $36.891M Beat $34.977M Estimate

&quot;Looking ahead, we are sharply focused on driving continuous improvement in execution across our entire operating platform in support of ongoing, robust, value-generating capital returns for our stockholders,&quot; aid&nbsp;Paul A. Lang, Arch&#39;s CEO.

ARCH

Arch Resources Expects Baltimore Port Closure Likely To Constrain Q2 Coking Coal Shipments

Kirby (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEX#NYSE">KEX</a>) reported quarterly earnings of $1.19 per share which beat the analyst consensus estimate of $0.98 by 21.43 percent. This is a 75 percent increase over earnings of $0.68 per share from the same period last year. The company reported quarterly sales of $808.02 million which beat the analyst consensus estimate of $784.57 million by 2.99 percent. This is a 7.67 percent increase over sales of $750.44 million the same period last year.

Kirby Q1 EPS $1.19 Beats $0.98 Estimate, Sales $808.02M Beat $784.57M Estimate

DTE Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DTE#NYSE">DTE</a>) reported quarterly earnings of $1.67 per share which missed the analyst consensus estimate of $1.73 by 3.47 percent.

DTE Energy Q1 2024 Adj. EPS $1.67 Misses $1.73 Estimate

Pool (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POOL#NASDAQ">POOL</a>) reported quarterly earnings of $2.04 per share which beat the analyst consensus estimate of $1.91 by 6.81 percent. The company reported quarterly sales of $1.10 billion which missed the analyst consensus estimate of $1.13 billion by 2.38 percent. This is a 8.86 percent decrease over sales of $1.21 billion the same period last year.

POOL

Pool Q1 2024 Adj EPS $2.04 Beats $1.91 Estimate, Sales $1.10B Miss $1.13B Estimate

Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) CEO Mark Zuckerberg revealed that the initial release of the <a href="https://www.benzinga.com/news/24/04/38330339/mark-zuckerbergs-meta-says-llama-3-beats-googles-gemini-mistral-and-jeff-bezos-backed-anthropics-cla">new version of Meta AI</a> has been well-received.
What Happened: During Meta's <a href="https://www.benzinga.com/news/earnings/24/04/38416273/meta-platforms-q1-earnings-highlights-facebook-owner-beats-estimates-but-guidance-higher-costs-ding">first-quarter earnings call</a>, Zuckerberg revealed that Meta AI, powered by the Llama 3 model has received positive feedback
This has led the company to initiate the rollout of Meta AI in English-speaking countries, with plans to expand to more languages and countries in the coming months.
"The initial rollout of Meta AI is going well. Tens of millions of people have already tried it. The feedback is very positive," Zuckerberg said during the call.
Zuckerberg emphasized that Meta Platforms follow a specific product development strategy. They release an early version of a product to a limited audience, gather feedback, and then improve it. Once they believe it&#8217;s ready, they make it available to more people.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
The initial release of the new Meta AI was last fall, and with this latest release, the company is moving to the next growth phase of its playbook.
"When I first checked in with our teams, the majority of feedback we were getting was people asking us to release Meta AI for them wherever they are."
See Also: <a href="https://www.benzinga.com/markets/equities/24/04/38423397/mark-zuckerberg-lays-down-how-meta-will-make-money-from-its-multi-billion-dollar-ai-bet">Mark Zuckerberg Lays Down How Meta Will Make Money From Its Multi-Billion Dollar AI Bet</a>
Why It Matters: Meta <a href="https://www.benzinga.com/news/24/04/38330339/mark-zuckerbergs-meta-says-llama-3-beats-googles-gemini-mistral-and-jeff-bezos-backed-anthropics-cla">released the Llama 3 AI model</a> earlier this month, taking on Alphabet Inc.'s Google Gemini and Jeff Bezos-backed Anthropic's Claude 3.
Zuckerberg highlighted that Meta AI with Llama 3 is now the "most intelligent AI assistant" that is available for free use.
Meta's new AI model also <a href="https://www.benzinga.com/news/24/04/38323489/facebook-parent-meta-debuts-new-features-in-meta-ai-real-time-image-creation-and-more">includes some unique features</a>, such as creating animations from still images and generating high-quality images so fast that they can be created and updated while the user is typing.
Check out more of Benzinga&#8217;s Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next: <a href="https://www.benzinga.com/news/24/04/38424000/mark-zuckerberg-shades-apple-vision-pro-once-again-calls-it-fashionable-ai-glasses-without-a-display">Mark Zuckerberg Shades Apple Vision Pro Once Again, Calls It &#8216;Fashionable AI Glasses Without A Display&#8217;</a>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Anthony Quintano on Flickr

Tech

Mark Zuckerberg Says 'Tens Of Millions' Users Have Already Tried Meta AI, And People Are 'Asking Us To Release...Wherever They Are'

The Company is reiterating its financial&nbsp;guidance&nbsp;for 2024.
<table align="center">
<tbody>
<tr>
<td>(in millions, except per share data)</td>
</tr>
<tr>
<td>CSB Total Revenue</td>
<td>$4,800&nbsp;-&nbsp;$5,000</td>
</tr>
<tr>
<td>CSB Adjusted EBITDA</td>
<td>$2,525&nbsp;-&nbsp;$2,625</td>
</tr>
<tr>
<td>Adjusted EPS</td>
<td>$0.60&nbsp;-&nbsp;$0.70</td>
</tr>
<tr>
<td>Adjusted Free Cash Flow
			(including interest rate swaps)</td>
<td>$700&nbsp;-&nbsp;$800</td>
</tr>
</tbody>
</table>

ADT Reiterated FY24 CSB Total Revenue of $4.8B-$5.0B, Adj EPS of $0.60-$0.70 Vs $0.58 Est

Guidance and investor update
Based on present demand trends and the current fuel price forecast and excluding the impact of special items, the company expects its second-quarter 2024 adjusted earnings per diluted share4 to be between $1.15 and $1.45. The company continues to expect its full-year adjusted earnings per diluted share4 to be between $2.25 and $3.25.

American Airlines Q2 Adj. EPS Outlook $1.15 - $1.45 Vs. $1.18 Estimate

American Airlines Reiterates FY24 Adj. EPS Outlook $2.25 - $2.35 Vs. $2.35 Estimate

Visteon is maintaining its full-year 2024&nbsp;guidance&nbsp;and anticipates&nbsp;adjusted EBITDA in the range of&nbsp;$470&nbsp;to&nbsp;$500 million, and adjusted free cash flow in the range of&nbsp;$155&nbsp;to&nbsp;$185 million.

Visteon Maintains Full-Year 2024 Guidance And Anticipates Sales Of $4.0B-$4.2B, Est $4.105B

Dover (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOV#NYSE">DOV</a>) reported quarterly earnings of $1.95 per share which beat the analyst consensus estimate of $1.87 by 4.28 percent. The company reported quarterly sales of $2.094 billion which beat the analyst consensus estimate of $2.035 billion by 2.91 percent. This is a 0.72 percent increase over sales of $2.079 billion the same period last year.

Dover Q1 2024 Adj EPS $1.95 Beats $1.87 Estimate, Sales $2.094B Beat $2.035B Estimate

Opera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPRA#NASDAQ">OPRA</a>) reported quarterly earnings of $0.17 per share which missed the analyst consensus estimate of $0.24 by 29.17 percent. This is unchanged from the same period last year. The company reported quarterly sales of $101.87 million which beat the analyst consensus estimate of $100.13 million by 1.74 percent. This is a 17.02 percent increase over sales of $87.05 million the same period last year.